Antitumor activity of 2,2-hydrazobis(3-chloro-1,4-naphthoquinone) against Walker 256(intramuscular) carcinosarcoma.
D000230:Adenocarcinoma / Q000188:drug therapy; D000818:Animals; D000970:Antineoplastic Agents / Q000008:administration & dosage*; D002279:Carcinoma 256, Walker / Q000188:drug therapy*; D006835:Hydrazones / Q000008:administration & dosage; D007939:Leukemia L1210 / Q000188:drug therapy; D009285:Naphthoquinones / Q000008:administration & dosage*; D009374:Neoplasms, Experimental / Q000188:drug therapy; D051381:Rats
D000970:Antineoplastic Agents; D006835:Hydrazones; D009285:Naphthoquinones